Health expert: Need for a new partnership with pharma industry under WHO

By |junij 24th, 2019|Clemens Martin Auer, European Health Forum Gastein, News, World Health Organisation|

The World Health Organisation (WHO) could provide a platform for a new partnership between the public health sector and the industry, from pharma to alcohol, Clemens Martin Auer, a candidate for the post of WHO Regional Director Europe, told EURACTIV in an interview.

Komentarji so izklopljeni za Health expert: Need for a new partnership with pharma industry under WHO

Investment in digital health and access to drugs at the core of Austrian Presidency

By |julij 10th, 2018|access to medicine, Clemens Martin Auer, drug pricing, early market authorisation, European Health Forum Gastein, Health Technology Assessment, News|

Austria’s EU Presidency will focus on “strong” investment in digital health as well as on regulatory issues when it comes to access to medicines, Dr Clemens Martin Auer told EURACTIV.com in an interview. Dr Clemens Martin Auer is the president of the...

Komentarji so izklopljeni za Investment in digital health and access to drugs at the core of Austrian Presidency

Andriukaitis: Supporting drug innovation is ‘the only way’

By |oktober 10th, 2017|drugs, European Health Forum Gastein, generic drugs, intellectual property rights, medicines, News, Vytenis Andriukaitis|

Backing innovation in the pharmaceutical market and developing new evidence-based economic models is the only way forward for future healthcare, according to EU Commissioner for Health and Food Safety Vytenis Andriukaitis.

Komentarji so izklopljeni za Andriukaitis: Supporting drug innovation is ‘the only way’

Pharma boss: Targeting drugs won’t make healthcare systems more sustainable

By |oktober 10th, 2017|Big pharma, EFPIA, European Health Forum Gastein, Health and Pharma, medicine, News, pharmaceuticals|

“Salami-slicing” the cost of medicines, which represent almost one-fifth of health system budgets and are subject to rigorous value assessments, won’t make healthcare systems more sustainable in the future, Nathalie Moll told EURACTIV.com in an interview.

Komentarji so izklopljeni za Pharma boss: Targeting drugs won’t make healthcare systems more sustainable

Gastein boss: Drugs access is ‘sensitive’ and cannot be viewed in isolation

By |oktober 4th, 2017|drug pricing, drugs, European Health Forum Gastein, healthcare, News|

Accessibility of medicines is a sensitive issue that must not be examined in isolation. Policymakers, academics, business and patients must be part of the discussion as well as “innovation” because access would not get the focus it needs without it, according to Dorli Kahr-Gottlieb.

Komentarji so izklopljeni za Gastein boss: Drugs access is ‘sensitive’ and cannot be viewed in isolation